New ITC Investigation Notices for Feb. 19
The International Trade Commission published notices in the Feb. 19 Federal Register on the following antidumping and countervailing duty (AD/CVD) injury, Section 337 patent or other trade proceedings (any notices that warrant a more detailed summary will be in another ITT article):
Sign up for a free preview to unlock the rest of this article
Export Compliance Daily combines U.S. export control news, foreign border import regulation and policy developments into a single daily information service that reliably informs its trade professional readers about important current issues affecting their operations.
- Certain Selective Thyroid Hormone Receptor-Beta Agonists, Processes for Manufacturing or Relating to Same, and Products Containing Same (ITC Inv. No. 337-TA-1352); Notice of a Commission Determination To Review a Final Initial Determination Finding a Violation of Section 337; Request for Written Submissions on Remedy, the Public Interest, and Bonding (here)
- Recent Trends in U.S. Services Trade: 2025 Annual Report (here)
- Methylene Diphenyl Diisocyanate (MDI) from China; Institution of Antidumping Duty Investigation and Scheduling of Preliminary Phase Investigation (here).